Expertise in
13
conditions

Dr. Nima Nabavizadeh

Radiation Oncology
OHSU Partners
Tuality Medical Group LLC
335 Se 8th Ave, 
Hillsboro, OR 
Accepting New Patients
Offers Telehealth
Expertise in
13
conditions
OHSU Partners
Tuality Medical Group LLC
335 Se 8th Ave, 
Hillsboro, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nima Nabavizadeh is a Radiation Oncologist in Hillsboro, Oregon. Dr. Nabavizadeh is highly rated in 13 conditions, according to our data. His top areas of expertise are Anal Cancer, Pancreatic Cancer, Melanoma of the Eye, and Plasmacytoma. Dr. Nabavizadeh is currently accepting new patients.

His clinical research consists of co-authoring 65 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Oklahoma College Of Medicine
Specialties
Radiation Oncology
Licenses
Radiology in OR
Hospital Affiliations
Ohsu Hospital And Clinics
Hillsboro Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

BridgeSpan
  • EPO
  • HMO
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Regence
  • EPO
  • PPO

Locations

TUALITY MEDICAL GROUP LLC
335 Se 8th Ave, Hillsboro, OR 97123
Other Locations
UNIVERSITY PROFESSIONAL SERVICES
3181 Sw Sam Jackson Park Rd, Portland, OR 97239

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: May 11, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
Enrollment Status: Active_not_recruiting
Publish Date: April 11, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Fluorouracil, Mitomycin
Study Phase: Phase 2
A Pilot Study to Assess Feasibility of Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients Awaiting Liver Transplantation
A Pilot Study to Assess Feasibility of Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients Awaiting Liver Transplantation
Enrollment Status: Terminated
Publish Date: March 07, 2025
Intervention Type: Other, Radiation
Study Phase: Not Applicable
Phase 1b Study to Assess the Safety of Neoadjuvant TAS-102 (Trifluridine/Tipiracil) With Concurrent Radiation in Previously Untreated Resectable Stage II and Stage III Rectal Cancer (FIERCE)
Phase 1b Study to Assess the Safety of Neoadjuvant TAS-102 (Trifluridine/Tipiracil) With Concurrent Radiation in Previously Untreated Resectable Stage II and Stage III Rectal Cancer (FIERCE)
Enrollment Status: Active_not_recruiting
Publish Date: February 14, 2025
Intervention Type: Drug, Radiation
Study Phase: Phase 1
Randomized Prospective Two-Arm Feasibility Trial of Stereotactic Body Radiation Therapy Versus Yttrium-90 Segmentectomy in Inoperable Hepatocellular Carcinoma
Randomized Prospective Two-Arm Feasibility Trial of Stereotactic Body Radiation Therapy Versus Yttrium-90 Segmentectomy in Inoperable Hepatocellular Carcinoma
Enrollment Status: Withdrawn
Publish Date: March 23, 2023
Intervention Type: Other, Procedure, Radiation
Study Phase: Phase 2
View 4 Less Clinical Trials

65 Total Publications

ASO Visual Abstract: Preoperative Chemoradiotherapy for Esophageal Carcinoma: A Single-Center 10-Year Experience of Low Versus High-Dose Neoadjuvant Chemoradiation.
ASO Visual Abstract: Preoperative Chemoradiotherapy for Esophageal Carcinoma: A Single-Center 10-Year Experience of Low Versus High-Dose Neoadjuvant Chemoradiation.
Journal: Annals of surgical oncology
Published: May 22, 2025
Similar Doctors
Expertise in
21
conditions
Dr. Arthur Y. Hung
Radiation Oncology
Expertise in
21
conditions
Dr. Arthur Y. Hung
Radiation Oncology

University Professional Services

3181 Sw Sam Jackson Park Rd, 
Portland, OR 
 (14.2 mi)
503-494-8311
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Arthur Hung is a Radiation Oncologist in Portland, Oregon. Dr. Hung is highly rated in 21 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Prostatectomy, and Orchiectomy. Dr. Hung is currently accepting new patients.

Expertise in
9
conditions
Dr. Timur E. Mitin
Radiation Oncology
Expertise in
9
conditions
Dr. Timur E. Mitin
Radiation Oncology

University Professional Services

3303 S Bond Ave, 
Portland, OR 
 (14.9 mi)
503-494-8311
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Timur Mitin is a Radiation Oncologist in Portland, Oregon. Dr. Mitin is highly rated in 9 conditions, according to our data. His top areas of expertise are Prostate Cancer, Anal Cancer, Small Cell Lung Cancer (SCLC), Prostatectomy, and Orchiectomy. Dr. Mitin is currently accepting new patients.

Expertise in
2
conditions
Dr. Vinayak Muralidhar
Radiation Oncology
Expertise in
2
conditions
Dr. Vinayak Muralidhar
Radiation Oncology

Kaiser Foundation Health Plan Of The Northwest

10100 Se Sunnyside Rd, 
Clackamas, OR 
 (21.2 mi)
800-813-2000
Experience:
9+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Vinayak Muralidhar is a Radiation Oncologist in Clackamas, Oregon. Dr. Muralidhar has been practicing medicine for over 9 years is highly rated in 2 conditions, according to our data. His top areas of expertise are Prostate Cancer, Penile Cancer, Anal Cancer, Prostatectomy, and Penectomy. Dr. Muralidhar is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nabavizadeh's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 44 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile